Effects of magnesium and potassium on Wolff-Parkinson-White syndrome

J Electrocardiol. 1996 Jan;29(1):11-5. doi: 10.1016/s0022-0736(96)80106-3.

Abstract

To investigate the effects of electrolytes on anterograde conduction via accessory pathways, 12 patients with Wolff-Parkinson-White syndrome received, while in sinus rhythm, intravenous KCl (7 mEq in 200 mL of 0.9% NaCl), MgSO4 (10 mL 20% in 200 mL of 0.9% NaCl), NaCl (0.9%, 200 mL), and procainamide (maximal dose, 10 mg/kg of body weight over a 5-minute period) in a randomized fashion. NaCl had no effect on preexcitation. Procainamide abolished preexcitation in seven patients, of whom five had a similar response with MgSO4 and four with KCl. The finding that potassium and magnesium transiently abolish preexcitation in some Wolff-Parkinson-White patients deserves further study, especially during tachyarrhythmias in patients with accessory pathways.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Arrhythmia Agents / administration & dosage*
  • Electrocardiography
  • Female
  • Heart Conduction System / drug effects*
  • Humans
  • Infusions, Intravenous
  • Magnesium / blood
  • Magnesium Sulfate / administration & dosage*
  • Male
  • Middle Aged
  • Myocardial Contraction / drug effects
  • Potassium / blood
  • Potassium Chloride / administration & dosage*
  • Procainamide / administration & dosage*
  • Wolff-Parkinson-White Syndrome / blood
  • Wolff-Parkinson-White Syndrome / drug therapy*
  • Wolff-Parkinson-White Syndrome / physiopathology

Substances

  • Anti-Arrhythmia Agents
  • Potassium Chloride
  • Magnesium Sulfate
  • Magnesium
  • Procainamide
  • Potassium